Blood transfusion in sickle cell disease

Area of Science:

• Hematology
• Transfusion Medicine

Background:

• Blood transfusion is critical for managing sickle cell disease (SCD), aiding in emergencies and preventing organ damage.
• Current transfusion practices in SCD are often based on anecdotal evidence, leading to potential overexposure in developed nations and limited access or unsafe practices in underdeveloped regions.
• The expanding role of transfusion medicine in SCD includes support for bone marrow and solid organ transplantation, and placental stem cell banking.

Purpose of the Study:

• To discuss the current modes and roles of blood transfusion in sickle cell disease.
• To review pharmacologic therapies used in conjunction with transfusions for SCD.
• To highlight the need for evidence-based guidelines through collaborative research.

Main Methods:

• This is a review and discussion of existing practices and literature regarding transfusion medicine in sickle cell disease.
• It synthesizes information on current transfusion protocols and therapeutic options.
• It identifies gaps in knowledge and proposes future research directions.

Main Results:

• Significant disparities exist in blood transfusion access and safety for sickle cell disease patients worldwide.
• Transfusion practices may lead to overutilization in some regions and underutilization or unsafe use in others.
• The scope of transfusion medicine in SCD is broadening with advancements in transplantation and stem cell banking.

Conclusions:

• Optimizing blood transfusion strategies in sickle cell disease requires robust, multicenter, randomized trials.
• Standardized, evidence-based guidelines are essential for safe and effective transfusion therapy in SCD.
• Future research should address all facets of transfusion medicine to improve patient outcomes globally.